ResearcherArmy Medical UniversityActive in the last 2 years
Shuai Xu
Matched on ORCID iD 0000-0001-5341-6200; OpenAlex author ID A5101871075. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter study. Co-author DOI 10.1016/j.hbpd.2025.04.008↗
- Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study. First author DOI 10.1097/js9.0000000000000296↗
- Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study. Co-author DOI 10.1007/s00423-021-02321-7↗
- Associations Between Poor Oral Hygiene and Risk of Pancreatic Cancer: A Meta-analysis of Observational Studies. Co-author DOI 10.1097/mpa.0000000000002143↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiuping Zhang · 3 shared papers, 2022–2025 · strength 0.56
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Paper Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter stu… DOI 10.1097/js9.0000000000000296↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Zhiming Zhao · 3 shared papers, 2022–2025 · strength 0.56
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Paper Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter stu… DOI 10.1097/js9.0000000000000296↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Rong Liu · 3 shared papers, 2022–2025 · strength 0.56
- Paper New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicente… DOI 10.1016/j.hbpd.2025.04.008↗
- Paper Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter stu… DOI 10.1097/js9.0000000000000296↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Wan Yee Lau · 2 shared papers, 2022–2023 · strength 0.33
- Paper Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter stu… DOI 10.1097/js9.0000000000000296↗
- Paper Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases… DOI 10.1007/s00423-021-02321-7↗
- Peizi Liu · 1 shared paper, 2025 · strength 0.23
- Xiaodong Tan · 1 shared paper, 2025 · strength 0.23
- Gang Zhang · 1 shared paper, 2022 · strength 0.20
- Minggen Hu · 1 shared paper, 2023 · strength 0.18
- Nan Jiang · 1 shared paper, 2022 · strength 0.15
- Qu Liu · 1 shared paper, 2022 · strength 0.15
- Guanghai Dai · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.